Relmada Therapeutics Inc (RLMD) — Net Asset Quality Index
Relmada Therapeutics Inc (RLMD) has a Net Asset Quality Index of 92.0% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $94.00 Million minus total liabilities of $7.49 Million yields net assets of $86.51 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check RLMD asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Relmada Therapeutics Inc Net Asset Quality Index Over Time (2012–2025)
This chart shows how Relmada Therapeutics Inc's Net Asset Quality Index has evolved across 15 annual periods from 2012 to 2025. As of December 2025, the index stands at 92.0%, representing net assets of $86.51 Million against total assets of $94.00 Million USD. See RLMD working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Relmada Therapeutics Inc (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Relmada Therapeutics Inc from 2012 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Relmada Therapeutics Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.0% | $86.51 Million | $94.00 Million | $7.49 Million | ▲ +14.5 pp |
| 2024 | 77.5% | $35.52 Million | $45.82 Million | $10.30 Million | ▼ -10.0 pp |
| 2023 | 87.5% | $85.36 Million | $97.55 Million | $12.19 Million | ▼ -4.3 pp |
| 2022 | 91.8% | $140.44 Million | $152.91 Million | $12.47 Million | ▼ -1.4 pp |
| 2021 | 93.3% | $208.26 Million | $223.33 Million | $15.06 Million | ▲ +3.9 pp |
| 2020 | 89.3% | $105.58 Million | $118.19 Million | $12.60 Million | ▼ -9.4 pp |
| 2019 | 98.8% | $115.68 Million | $117.14 Million | $1.46 Million | ▲ +279.6 pp |
| 2018 | -180.9% | $-5.51 Million | $3.05 Million | $8.56 Million | ▼ -232.3 pp |
| 2017 | 51.5% | $1.46 Million | $2.84 Million | $1.38 Million | ▼ -17.3 pp |
| 2016 | 68.7% | $7.04 Million | $10.24 Million | $3.20 Million | ▲ +32.6 pp |
| 2015 | 36.1% | $8.81 Million | $24.39 Million | $15.58 Million | ▲ +0.0 pp |
| 2014 | 36.1% | $8.81 Million | $24.39 Million | $15.58 Million | ▲ +40.4 pp |
| 2014 | -4.3% | $-1.11 Million | $25.76 Million | $26.87 Million | ▲ +0.0 pp |
| 2013 | -4.3% | $-1.11 Million | $25.76 Million | $26.87 Million | ▼ -66.2 pp |
| 2012 | 61.9% | $11.36K | $18.35K | $7.00K | — |